- [PRESSWIRE] PALO ALTO, Calif., June 19, 2019 — Vynca, the nation’s leading advance care planning solution, announced today that it has secured $10.3 million in Series B funding from First Trust Capital Partners, OCA Ventures, and Spectrum Health Ventures, in addition to key strategic individual investors.
- [PRESSWIRE] Budapest – June 13, 2019 — Alport syndrome (AS) is a hereditary type IV collagen disease that leads to progressive proteinuria, renal fibrosis, and kidney failure.
- [PRESSWIRE] Budapest – June 13, 2019 — High cardiovascular morbidity and mortality remain a persisting problem in patients with CKD. Many efforts have been made in subjects with normal kidney function to prevent and to reduce the progression of cardiovascular diseases.
- [PRESSWIRE] Budapest – June 13, 2019 — Historically, the number of RCTs performed in the ESRD population has been very low compared to other medical subspecialties. Furthermore, several of the few large RCTs conducted in patients with ESRD have yielded inconclusive or negative results, dampening enthusiasm for future investment in similar trials.
- [PRESSWIRE] NEWARK, Del., June 12, 2019 — Laurel Bridge Software, a provider of software solutions that enable health systems to automate and centrally manage their medical imaging workflows, announces their participation in the upcoming Society for Imaging Informatics in Medicine (SIIM) Annual Meeting in Aurora, CO, June 26 – 28.
- [PRESSWIRE] LAGUNA HILLS, Calif. – May 1, 2019 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, will present interim results from its large PREDICT study during a poster presentation (Abstract ID: 581643), titled “Interim Analysis of the DCISionRT PREDICT Study: Clinical Utility of a Biologic Signature Predictive of Radiation Therapy (RT) Benefit in Patients with DCIS”, at the American Society of Breast Surgeons (ASBrS) Annual Meeting in Dallas, TX.
- [PRESSWIRE] Parma – April 26, 2019 — The recently published CREDENCE study [1] showed that SGLT2 inhibitors can slow progression of chronic kidney disease (CKD) in diabetes patients in addition to the effects seen with RAAS blockade. The study results were presented at the World Nephrology Congress in Melbourne and showed that Canagliflozin was associated with a 34% risk reduction of the renal end point (end stage renal disease, doubling of serum creatinine or renal death). The previous day, the SONAR study had shown that the selective endothelin A receptor antagonist, atrasentan, reduced the risk of renal events in a specially selected CKD cohort with diabetes to a similar extent (35%).
- [PRESSWIRE] SAN JOSE, Calif., March 21, 2019 — BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 43,645,000 shares of common stock at a price of $0.09 per share in a registered direct offering. The gross proceeds of the offering are expected to be approximately $3.9 million.
- [PRESSWIRE] Parma – 18 April 2019 — Kidney transplantation is the best renal replacement therapy available. Although survival and quality of life are significantly better compared to dialysis patients, transplant recipients nevertheless have a significantly higher cardiovascular morbidity and mortality than healthy people. One recently published study [1] shows current data and derives important conclusions for further long-term improvements in outcomes after kidney transplantation – a highly topical issue, especially for cost reasons and in the event of organ or donor scarcity.
- [PRESSWIRE] Parma – 10 April, 2019 — Chronic kidney disease (CKD) is increasingly recognized as a systemic condition. It also impacts upon other organ systems and in recent years much attention has focussed specifically on the link between the kidneys and the heart. There is also an association between brain dysfunction and kidney disease; new data shows that even mild CKD correlates with impairment of cognitive function. A new review by Professor Giovambattista Capasso summarizes the current evidence in this field.
- [PRESSWIRE] NEW YORK and BASEL, Switzerland, March 19, 2019 — Today Roivant subsidiary Urovant Sciences announced topline results from its Phase 3 EMPOWUR trial of vibegron in patients with overactive bladder. Vibegron achieved statistically significant improvements over placebo on both co-primary endpoints of the study as well as all seven key secondary endpoints. Over 30 million Americans over the age of 40 suffer from overactive bladder.
- [PRESSWIRE] Parma – 05 March, 2019 — “Kidney health for everyone everywhere” – ERA-EDTA has helped to put this motto into practice by offering support for young nephrologists living in disadvantage areas.
- [PRESSWIRE] Parma – 05 March, 2019 — 850 million people worldwide are affected by kidney disease [1] – a worrying figure, and one that continues to rise. Prevention of chronic kidney disease is therefore more important than ever, as Professor Carmine Zoccali (Reggio Calabria, Italy), President of the ERA-EDTA, emphasizes on the occasion of World Kidney Day on March 14, 2019.
- [PRESSWIRE] Brussels, 28 February 2019 – Today, Digestive Cancers Europe launched a campaign to promote colorectal cancer screening at the occasion of the start of European Colon Cancer Awareness Month (ECCAM). The event took place at the European Parliament and was hosted by MEP Lieve Wierinck (ALDE).
- [PRESSWIRE] Parma – 26 February, 2019 — A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.
- [PRESSWIRE] – Parma – February 18, 2019 — Results bear one clear key message: good treatment is important! Patients in whom the acidosis had been properly controlled by adequate treatment had better growth and better kidney function than those with inadequate treatment.
- [PRESSWIRE] Germany – 21 December, 2018 — A study published in JAMA [1] showed: Nephrologists treat the most complex patients. As ERA-EDTA president Professor Carmine Zoccali explains, kidney patients are highly vulnerable and need special care, but nephrology is a neglected discipline in many European healthcare systems. According to the “European Renal Association – European Dialysis and Transplant Association” (ERA-EDTA) it is time for a paradigm shift. There is a need for a better financial funding of nephrology – as well as more efforts to raise awareness for kidney disease in the population.
- [PRESSWIRE] Germany – 17 December, 2018 — The EKHA project “Improving Organ Donation and Transplantation in the EU” will be launched on the European Commission’s Health Policy Platform in 2019, an interactive tool to boost discussions about public health concerns and to share knowledge and best practices.
- [PRESSWIRE] London, United Kingdom – 22 October, 2018 — Yorkshire-headquartered technology specialist Vapour Cloud has launched the first video tool of its kind for the UK healthcare sector, powered by a free, simple SMS.
- [PRESSWIRE] London, United Kingdom – 09 October, 2018 — UK-based leading specialist digital healthcare agency, Pulse, today retains its Level 4 Content Agency certification status with Veeva Systems – the highest level possible that can be achieved by an industry agency partner. Pulse is just one of a handful of agencies to be awarded and retain their accreditation.
- [PRESSWIRE] Paris – September 12, 2018 — Tattooing has gained tremendous popularity in Western countries. In Australia, Finland France and Germany, approximately 10% of the populations have at least one tattoo [1]. The ‘tattoo craze’ is particularly strong among the young generation, in which every third or fourth person has a tattoo.
- [PRESSWIRE] Paris – September 12, 2018 — The sun is one of the most dangerous carcinogens, yet people who work outdoors are inadequately protected. Since 2014, data on the UV exposure of outdoor workers (such as farmers, road workers, seasonal harvest workers, building workers, roofers, etc.) have been collected in Germany as part of the GENESIS-UV project – with alarming results.
- [PRESSWIRE] Paris – September 12, 2018 — Psoriasis is a chronic, non-communicable skin disease characterized by bright, silvery-white scales on reddened (inflamed) patches of skin, mainly on the arms and legs, the scalp, but also on many other areas of the body, including the genitals.
- [PRESSWIRE] Paris – September 12, 2018 — HPV genital infections are the most frequent sexually transmitted infections of viral origin and definitely represent a global burden with significant oncogenic potential. HPV infection causes external genital warts, and some HPV types are strongly associated with cancer or precancerous lesions. HPV induced cancers are mostly (but not only!) those of the ano-genital region, such as cervical, anal, vulvar, penile cancer, etc., but the cancers of the mouth and/or throat are also included.
- [PRESSWIRE] Parma – 12 September, 2018 — A study, which has been published in NDT [1] today shows that caffeine consumption is associated with a lower mortality rate in CKD patients. This relationship has already been observed in the general population. Although this study shows that this association may persist if caffeine is consumed through caffeine-containing soft drinks, the president of the European Renal Nutrition Working Group, Professor Denis Fouque, recommends CKD patients not to consume these soft drinks, but to drink coffee or tea instead.
- [PRESSWIRE] London, United Kingdom – 23 August, 2018 — Yorkshire tech firm Vapour Cloud has developed a secure, automated appointment booking service for the NHS.
- [PRESSWIRE] Parma – 06 August, 2018 — New NDT study [1] shows that `normal´ pre-dialysis blood pressure measurement is not reliable. “Without performing extended ambulatory BP recordings (44h – 48h) we approvingly accept an error rate of about 30% in the diagnosis of hypertension in dialysis patients, a highly vulnerable patient group with a dramatically elevated cardiovascular risk. This is why EURECA-m recommends ambulatory blood pressure monitoring as gold standard for the diagnosis for hypertension in hemodialysis patient.”
- [PRESSWIRE] HUNTINGTON BEACH, Calif., Aug. 3, 2018 — Building on the company’s pioneering approach to prevention, diagnosis and treatment of mental illness and comorbid conditions, D’Amore Healthcare today announced the availability of a new program that will help organizations prevent associate fatigue and licit or illicit substance dependence.
- [PRESSWIRE] Parma – 10 July, 2018 — An Indian working group published five cases of nephrotic syndrome caused by MN with evidence of chronic mercury poisoning due to consumption of traditional Indian medicines such as Siddha and Ayurveda. The article was published in “Clinical Kidney Journal” (ckj), an official journal of the ERA-EDTA. “As long as there are no strict quality controls for substances used in traditional medicine, we have to warn our patients: Mercury poisoning can lead to MN as well as to many other severe health problems, affecting the brain, the gut and the kidneys.”
- [PRESSWIRE] Parma – 29 June, 2018 — The ERA-EDTA and the Japanese Society of Nephrology (JSN) are delighted to announce continuing progress in their joint collaboration in the important field of mineral and bone disorder in chronic kidney disease (CKD-MBD). This serious condition affects most people as their kidney disease progresses.